中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
13期
134-135
,共2页
急性心肌梗死%纳洛酮%尿激酶
急性心肌梗死%納洛酮%尿激酶
급성심기경사%납락동%뇨격매
Acute myocardial infarction%Naloxone%Urokinase
目的:探讨纳洛酮联合尿激酶对于治疗急性心肌梗死(AMI)的临床效果。方法将该院76例AMI患者,均分成两组,各38例,两组在均行常规治疗的基础上,对照组给予尿激酶治疗,治疗组给予纳洛酮与尿激酶联合治疗。统计两组在不同时间段的心电图,并对比治疗前后两组的疗效。结果对照组的总有效率为65.8%,而治疗组的总有效率为92.1%,治疗组的疗效优于对照组,差异有统计学意义(P<0.05)。从症状体征的对比上,治疗组的各指标恢复情况也优于对照组,差异有统计学意义(P<0.05)。结论相较于单纯使用尿激酶而言,纳洛酮联合尿激酶对于治疗AMI的有效性更高,更有助于缓解症状,值得临床推广。
目的:探討納洛酮聯閤尿激酶對于治療急性心肌梗死(AMI)的臨床效果。方法將該院76例AMI患者,均分成兩組,各38例,兩組在均行常規治療的基礎上,對照組給予尿激酶治療,治療組給予納洛酮與尿激酶聯閤治療。統計兩組在不同時間段的心電圖,併對比治療前後兩組的療效。結果對照組的總有效率為65.8%,而治療組的總有效率為92.1%,治療組的療效優于對照組,差異有統計學意義(P<0.05)。從癥狀體徵的對比上,治療組的各指標恢複情況也優于對照組,差異有統計學意義(P<0.05)。結論相較于單純使用尿激酶而言,納洛酮聯閤尿激酶對于治療AMI的有效性更高,更有助于緩解癥狀,值得臨床推廣。
목적:탐토납락동연합뇨격매대우치료급성심기경사(AMI)적림상효과。방법장해원76례AMI환자,균분성량조,각38례,량조재균행상규치료적기출상,대조조급여뇨격매치료,치료조급여납락동여뇨격매연합치료。통계량조재불동시간단적심전도,병대비치료전후량조적료효。결과대조조적총유효솔위65.8%,이치료조적총유효솔위92.1%,치료조적료효우우대조조,차이유통계학의의(P<0.05)。종증상체정적대비상,치료조적각지표회복정황야우우대조조,차이유통계학의의(P<0.05)。결론상교우단순사용뇨격매이언,납락동연합뇨격매대우치료AMI적유효성경고,경유조우완해증상,치득림상추엄。
Objective Discussion naloxone combined with urokinase for acute myocardial infarction (AMI) clinical results.Methods Our hospital76 cases of AMI patients were divided into two groups, each of 38 cases, the basis of both groups underwent conven-tional treatment, the control group was given urokinase therapy, the treatment group received naloxone combination therapy with urokinase. Statistical two different time periods in the electrocardiogram, and compare the efficacy of the two groups before and af-ter treatment.Results The total effective rate of the control group 65.8%, while the total effective treatment group was 92.1%in the treatment group than the control group, the difference was significant, there is(P<0.05), the difference was statistically significant. From the comparison of symptoms and signs, and each treatment group recovery indicators are better than the control group, the differences are significant, there is (P<0.05)5, the difference was statistically significant.Conclusion Compared to the simple use of urokinase, the naloxone combined with urokinase for higher effectiveness of the treatment of AMI, but also help relieve symp-toms, worthy of promotion.